{"id":"W2559317205","doi":"10.1093/annonc/mdw435.26","title":"gynaecological cancers A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cohort; Neutropenia; Placebo; Chemotherapy; Progression-free survival; Ovarian cancer; Oncology; Surgery; Cancer; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001598788,0.001772399,0.003496168,0.0004411646,0.0004419471,0.00105734,0.00121541,0.001641206,0.01051005],"category_scores_gemma":[0.002128298,0.0008313179,0.002008799,0.0004060598,0.001344657,0.00124516,0.0004833901,0.004415965,0.001392475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006968251,"about_ca_system_score_gemma":0.001090528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001086853,"about_ca_topic_score_gemma":0.002537969,"domain_scores_codex":[0.9994965,0.0002800383,0.00002464263,0.0001011349,0.00002796442,0.00006967142],"domain_scores_gemma":[0.9992365,0.0002270858,0.0001557933,0.00009642701,0.00003336241,0.000250834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9816021,0.002313252,0.0002465122,0.0004397613,0.0005561522,0.0000211293,0.00003170849,0.0002400792,0.001482488,0.00008161128,0.0009452091,0.01203994],"study_design_scores_gemma":[0.9807717,0.01774566,0.0005896044,0.00001415757,0.0001458095,0.00001961395,0.000008449156,0.0001689902,0.0001140063,0.0001033725,0.0003116267,0.000006978313],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758196,0.008978673,0.001024926,0.001625061,0.001325007,0.004234801,0.002761844,0.0004057316,0.003824304],"genre_scores_gemma":[0.9773716,0.003743228,0.002393773,0.001859364,0.0006804155,0.003966267,0.002333431,0.00008009691,0.007571858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01051005,"threshold_uncertainty_score":0.03515965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1192669490677701,"score_gpt":0.4135565817748023,"score_spread":0.2942896327070322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}